470 related articles for article (PubMed ID: 30466668)
41. Colonoscopy versus computed tomography colonography for colorectal cancer screening.
Akhtar R; Lee M; Itzkowitz SH
Mt Sinai J Med; 2010; 77(2):214-24. PubMed ID: 20309919
[TBL] [Abstract][Full Text] [Related]
42. The role of virtual colonoscopy in colorectal screening.
Patel JD; Chang KJ
Clin Imaging; 2016; 40(2):315-20. PubMed ID: 26298421
[TBL] [Abstract][Full Text] [Related]
43. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
[TBL] [Abstract][Full Text] [Related]
44. Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.
Ebner DW; Finney Rutten LJ; Miller-Wilson LA; Markwat N; Vahdat V; Ozbay AB; Limburg PJ
Cancer Prev Res (Phila); 2024 Jun; 17(6):275-280. PubMed ID: 38561018
[TBL] [Abstract][Full Text] [Related]
45. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
46. Screening for colorectal cancer.
Saliangas K
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
[TBL] [Abstract][Full Text] [Related]
47. Screening for colorectal cancer.
Choi Y; Sateia HF; Peairs KS; Stewart RW
Semin Oncol; 2017 Feb; 44(1):34-44. PubMed ID: 28395761
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
[TBL] [Abstract][Full Text] [Related]
49. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
50. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review.
Lieberman D; Ladabaum U; Cruz-Correa M; Ginsburg C; Inadomi JM; Kim LS; Giardiello FM; Wender RC
JAMA; 2016 Nov; 316(20):2135-2145. PubMed ID: 27893135
[TBL] [Abstract][Full Text] [Related]
51. Impact of screening colonoscopy on outcomes in colorectal cancer.
Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
[TBL] [Abstract][Full Text] [Related]
52. Developments in Screening Tests and Strategies for Colorectal Cancer.
Sovich JL; Sartor Z; Misra S
Biomed Res Int; 2015; 2015():326728. PubMed ID: 26504799
[TBL] [Abstract][Full Text] [Related]
53. Screening and diagnosis for colorectal cancer: present and future.
Labianca R; Merelli B
Tumori; 2010; 96(6):889-901. PubMed ID: 21388049
[TBL] [Abstract][Full Text] [Related]
54. [Necessity and feasibility of screening for colorectal cancer in China].
Zhang SZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
[TBL] [Abstract][Full Text] [Related]
55. A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer.
Bechtold ML; Ashraf I; Nguyen DL
South Med J; 2016 Apr; 109(4):248-55. PubMed ID: 27043809
[TBL] [Abstract][Full Text] [Related]
56. Evidence-Based, Reality-Driven Colorectal Cancer Screening Guidelines: The Critical Relationship of Adherence to Effectiveness.
Winawer SJ; Fischer SE; Levin B
JAMA; 2016 May; 315(19):2065-6. PubMed ID: 27187294
[No Abstract] [Full Text] [Related]
57. Screening for colorectal cancer in individuals at average risk: current methods and emerging issues.
Lieberman D
JAMA Intern Med; 2014 Jan; 174(1):10-1. PubMed ID: 24145734
[No Abstract] [Full Text] [Related]
58. The toll of not screening for colorectal cancer.
Chen C; Hoffmeister M; Brenner H
Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):1-3. PubMed ID: 27897033
[No Abstract] [Full Text] [Related]
59. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
60. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
